ReviewView (Beijing, China)2022
Therapeutic antibodies under development for SARS-CoV-2.
Zetong Ma et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ReviewView (Beijing, China)2022
Zetong Ma et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.